Home600645 • SHA
Follow
Vcanbio Cell & Gene Engineering Corp Ltd
Previous close
¥16.26
Day range
¥16.06 - ¥16.31
Year range
¥12.88 - ¥21.77
Market cap
7.51B CNY
Avg Volume
5.36M
P/E ratio
57.60
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Revenue | 404.29M | -0.77% |
Operating expense | 229.06M | -6.41% |
Net income | 49.84M | 0.24% |
Net profit margin | 12.33 | 1.07% |
Earnings per share | — | — |
EBITDA | 90.13M | 18.12% |
Effective tax rate | 25.95% | — |
Balance Sheet
Total assets
Total liabilities
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 1.52B | 15.01% |
Total assets | 5.42B | 3.74% |
Total liabilities | 1.61B | 0.68% |
Total equity | 3.82B | — |
Shares outstanding | 467.95M | — |
Price to book | 2.06 | — |
Return on assets | 2.97% | — |
Return on capital | 4.08% | — |
Cash Flow
Net change in cash
(CNY) | Sep 2023info | Y/Y change |
---|---|---|
Net income | 49.84M | 0.24% |
Cash from operations | 72.67M | 0.20% |
Cash from investing | -16.72M | 35.11% |
Cash from financing | -6.01M | 17.93% |
Net change in cash | 46.65M | -25.81% |
Free cash flow | -88.70M | — |
About
Founded
1992
Website
Employees
2,332